Newton One Investments’s Pfizer PFE Stock Holding History

Newton One Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.82K	Buy	+200	New	+$5.23K	﹤0.01%	131

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Newton One Investments's PFE Position: Q2 2026 in Review

Newton One Investments opened a new position in Pfizer (PFE) in Q2 2026: 200 shares worth $4.82K. The stake represents ﹤0.01% of the portfolio and ranks #131 among its holdings.

2,059 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Newton One Investments held 200 shares of Pfizer worth $4.82K as of Q2 2026.
Pfizer was a new Newton One Investments position in Q2 2026.
Pfizer made up ﹤0.01% of Newton One Investments's portfolio in Q2 2026, its #131 holding.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Newton One Investments's 13F filing for Q2 2026, filed 22 Jul 2026.